ROSSI, OLIVIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 339
EU - Europa 260
AS - Asia 90
AF - Africa 1
Totale 690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 339
IT - Italia 94
PL - Polonia 52
IE - Irlanda 44
HK - Hong Kong 36
RU - Federazione Russa 26
SE - Svezia 26
CN - Cina 24
SG - Singapore 14
GB - Regno Unito 8
JO - Giordania 8
IN - India 3
CH - Svizzera 2
DE - Germania 2
FR - Francia 2
ID - Indonesia 2
VN - Vietnam 2
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
IR - Iran 1
UA - Ucraina 1
Totale 690
Salva come PNG Salva come JPEG
Città #
Warsaw 52
Fairfield 46
Dublin 44
Ashburn 39
Chandler 26
Hong Kong 26
Moscow 24
Cambridge 23
Wilmington 22
Seattle 20
Woodbridge 18
Houston 17
Altamura 14
Lawrence 14
Florence 13
Shanghai 13
Luni 12
Singapore 11
Buffalo 8
New York 8
Princeton 8
Ann Arbor 7
Beijing 7
Boston 5
Livorno 5
San Diego 5
Milan 4
Campi Bisenzio 3
Kent 3
Medford 3
Rome 3
Washington 3
Boardman 2
Dong Ket 2
Lambeth 2
Latina 2
London 2
Monopoli 2
Norwalk 2
Parma 2
Redwood City 2
Romainville 2
Sommacampagna 2
Varese 2
Zurich 2
Bari 1
Chicago 1
Cologne 1
Copenhagen 1
Edinburgh 1
Frankfurt am Main 1
Helsinki 1
Hillsboro 1
Kolkata 1
Laurel 1
Macclesfield 1
Nanchang 1
Phoenix 1
Pune 1
Redmond 1
Sant'elpidio A Mare 1
Scarperia e San Piero 1
Sesto Fiorentino 1
Wuhan 1
Totale 551
Salva come PNG Salva come JPEG
Nome #
Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study 135
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 79
Migrants and allergy: a new view of the atopic march 70
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 57
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 55
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 53
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 53
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 49
Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real life study 35
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 29
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 23
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 19
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 17
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 14
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 8
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 7
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 5
Totale 708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 3 22 2 10 21 17 14 16 14 9 7 3
2020/2021107 6 6 0 15 19 17 4 3 16 4 10 7
2021/202249 0 0 0 2 0 11 0 1 6 4 11 14
2022/2023191 13 40 14 6 6 30 28 14 19 4 7 10
2023/2024210 2 14 21 18 28 22 11 40 4 21 10 19
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 708